Literature DB >> 18569459

Cannabinoid rescue of striatal progenitor cells in chronic Borna disease viral encephalitis in rats.

Marylou V Solbrig1, Neal Hermanowicz.   

Abstract

A growing number of environmental and pharmacologic manipulations have been shown to influence adult neurogenesis. Borna disease virus (BDV) in rats causes cortical and subcortical infection with extrapyramidal motor symptoms, and hippocampal infection suppresses neurogenesis. Given the known effects of cannabinoids in promoting neural progenitor cell survival, the authors examined in vivo effects of chronic BDV infection in rats on BrdU-positive progenitor cells in striatum, together with neuroprotective actions of cannabinoids. Birth and survival of BrdU-positive progenitor cells in striatum of BDV-infected rats treated with a general cannabinoid agonist (WIN 55,212 1 mg/kg i.p. b.i.d. x 7 days) were examined, as well as anti-inflammatory, antiviral, and nutritional effects of cannabinoids. Cannabinoid treatment protected BrdU-positive progenitor cells in striatum that were susceptible to virus-induced injury (p < .01) through suppression of microglia activation (p < .001). As a consequence of their anti-inflammatory actions and support of neural progenitor cell survival, cannabinoids may be adjunctive treatment for encephalitides with microglial inflammation and neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18569459     DOI: 10.1080/13550280802074521

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  84 in total

Review 1.  Cannabinoids and neuroprotection in basal ganglia disorders.

Authors:  Onintza Sagredo; Moisés García-Arencibia; Eva de Lago; Simone Finetti; Alessandra Decio; Javier Fernández-Ruiz
Journal:  Mol Neurobiol       Date:  2007-06-23       Impact factor: 5.590

2.  Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: importance of antioxidant and cannabinoid receptor-independent properties.

Authors:  Moisés García-Arencibia; Sara González; Eva de Lago; José A Ramos; Raphael Mechoulam; Javier Fernández-Ruiz
Journal:  Brain Res       Date:  2006-12-28       Impact factor: 3.252

3.  Abnormal development of the hippocampal dentate gyrus in mice lacking the CXCR4 chemokine receptor.

Authors:  Meiling Lu; Elizabeth A Grove; Richard J Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-30       Impact factor: 11.205

4.  Borna disease virus phosphoprotein binds a neurite outgrowth factor, amphoterin/HMG-1.

Authors:  W Kamitani; Y Shoya; T Kobayashi; M Watanabe; B J Lee; G Zhang; K Tomonaga; K Ikuta
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

5.  Metallothioneins and zinc dysregulation contribute to neurodevelopmental damage in a model of perinatal viral infection.

Authors:  Brent L Williams; Kavitha Yaddanapudi; Cassandra M Kirk; Arya Soman; Mady Hornig; W Ian Lipkin
Journal:  Brain Pathol       Date:  2006-01       Impact factor: 6.508

6.  Morphine-mediated deterioration of oxidative stress leads to rapid disease progression in SIV/SHIV-infected macaques.

Authors:  Antonio Pérez-Casanova; Richard J Noel; Vanessa Rivera-Amill; Kazim Husain; Anil Kumar
Journal:  AIDS Res Hum Retroviruses       Date:  2007-08       Impact factor: 2.205

7.  Pharmacological separation of cannabinoid sensitive receptors on hippocampal excitatory and inhibitory fibers.

Authors:  N Hájos; T F Freund
Journal:  Neuropharmacology       Date:  2002-09       Impact factor: 5.250

8.  Inflammation is detrimental for neurogenesis in adult brain.

Authors:  Christine T Ekdahl; Jan-Hendrik Claasen; Sara Bonde; Zaal Kokaia; Olle Lindvall
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-27       Impact factor: 11.205

Review 9.  Borna disease--neuropathology and pathogenesis.

Authors:  G Gosztonyi; H Ludwig
Journal:  Curr Top Microbiol Immunol       Date:  1995       Impact factor: 4.291

10.  Cannabinoids inhibit neurodegeneration in models of multiple sclerosis.

Authors:  Gareth Pryce; Zubair Ahmed; Deborah J R Hankey; Samuel J Jackson; J Ludovic Croxford; Jennifer M Pocock; Catherine Ledent; Axel Petzold; Alan J Thompson; Gavin Giovannoni; M Louise Cuzner; David Baker
Journal:  Brain       Date:  2003-07-22       Impact factor: 13.501

View more
  5 in total

Review 1.  The endocannabinoid system and the regulation of neural development: potential implications in psychiatric disorders.

Authors:  Ismael Galve-Roperh; Javier Palazuelos; Tania Aguado; Manuel Guzmán
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-07-09       Impact factor: 5.270

2.  A synthetic cannabinoid agonist promotes oligodendrogliogenesis during viral encephalitis in rats.

Authors:  Marylou V Solbrig; Yijun Fan; Neal Hermanowicz; Maria Grazia Morgese; Andrea Giuffrida
Journal:  Exp Neurol       Date:  2010-09-09       Impact factor: 5.330

3.  Borna disease virus infects human neural progenitor cells and impairs neurogenesis.

Authors:  Dragan Brnic; Vladimir Stevanovic; Marielle Cochet; Cécilia Agier; Jennifer Richardson; Claudia N Montero-Menei; Ollivier Milhavet; Marc Eloit; Muriel Coulpier
Journal:  J Virol       Date:  2011-12-21       Impact factor: 5.103

4.  Cannabinoids and Viral Infections.

Authors:  Carol Shoshkes Reiss
Journal:  Pharmaceuticals (Basel)       Date:  2010-06-01

5.  Impaired neurogenesis by HIV-1-Gp120 is rescued by genetic deletion of fatty acid amide hydrolase enzyme.

Authors:  H K Avraham; S Jiang; Y Fu; E Rockenstein; A Makriyannis; J Wood; L Wang; E Masliah; S Avraham
Journal:  Br J Pharmacol       Date:  2015-08-21       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.